To read more on this topic click here.
New molecule could reverse neurodegeneration in Parkinson’s
Author: Simge Eva DoganPublished: 11 October 2018
Prep: Cook: Serves:
Researchers at a university in Spain have discovered a new molecule which they claim can block and reverse neurodegeneration in Parkinson’s.
The molecule – named SynuClean-D – is able to reduce alpha-synuclein aggregations which cause degeneration.
The study – published in science journal ‘PNAS’ – explains how researchers at the Universitat Autònoma de Barcelona, Spain, tested over 14,000 molecules before discovering SynuClean-D.
They then tested the molecule on a Caenorhabditis worm – one of the most commonly used animals when researching neurodegenerative diseases – finding that it boosted its mobility and protected it from neural degeneration.
Salvador Ventura, the study coordinator, said: “Everything seems to indicate that the molecule we identified, the SynuClean-D, may provide therapeutic applications for the treatment of neurodegenerative diseases such as Parkinson’s in the future.”
For more information on the latest Parkinson’s research please visit the EPDA website.
Share this story
“There is hope for turning this condition around”
Sheila Roy charts the 'life-changing' effects of new gene therapyREAD MORE
National Parkinson Foundation and Parkinson’s Disease Foundation complete merger
New organisation hopes to “champion a better future”READ MORE
Singapore runs for Parkinson’s
Parkinson Society Singapore fun run to raise awareness and fundsREAD MORE